Background-The desmosomal cadherin desmoglein 2 (Dsg2) localizes to the intercalated disc coupling adjacent cardiomyocytes. Desmoglein 2 gene (DSG2) mutations cause arrhythmogenic cardiomyopathy (AC) in human and transgenic mice. AC is characterized by arrhythmia, cardiodilation, cardiomyocyte necrosis with replacement fibrosis, interstitial fibrosis, and intercalated disc dissociation. The genetic DSG2 constellations encountered are compatible with loss of adhesion and altered signaling. To further elucidate pathomechanisms, we examined whether heart-specific Dsg2 depletion triggers cardiomyopathy. Methods and Results-Because DSG2 knockouts die during early embryogenesis, mice were prepared with cardiomyocytespecific DSG2 ablation. Healthy transgenic animals were born with a functional heart presenting intercalated discs with incorporated desmosomal proteins. Dsg2 protein expression was reduced below 3% in the heart. All animals developed AC during postnatal growth with pronounced chamber dilation, calcifying cardiomyocyte necrosis, aseptic inflammation, interstitial and focal replacement fibrosis, and conduction defects with altered connexin 43 distribution. Electron microscopy revealed absence of desmosome-like structures and regional loss of intercalated disc adhesion. Mice carrying 2 mutant DSG2 alleles coding for Dsg2 lacking part of the adhesive EC1-EC2 domains present an indistinguishable phenotype, which is similar to that observed in human AC patients. Conclusions-The observations show that the presence of Dsg2 is not essential for late heart morphogenesis and for cardiac contractility to support postnatal life. On increasing mechanical demands, heart function is severely compromised as evidenced by the onset of cardiomyopathy with pronounced morphological alterations. We propose that loss of Dsg2 compromises adhesion, and that this is a major pathogenic mechanism in DSG2-related and probably other desmosomerelated ACs.
A rrhythmogenic cardiomyopathy (AC), also referred to as arrhythmogenic right ventricular cardiomyopathy or arrhythmogenic right ventricular dysplasia, is a genetic heart disease. 1 It affects primarily the right ventricle, but left ventricular involvement is also common. Ventricular tachyarrhythmia, chamber dilation, and fibrofatty replacement of cardiac tissue are key features of human AC. During its acute phase, the disease is a frequent cause of sudden cardiac death in young athletes and may lead to heart failure in the chronic phase.
Clinical Perspective on p 563
Mutations in desmosomal genes are the most common genetic alterations in AC, which has been referred to as a disease of the desmosome. 1 Mutations in genes encoding phospholamban, desmin, transforming growth factor-β3, transmembrane protein 43, and the ryanodine receptor 2 have also been identified. 2 Desmosome-like structures are part of the intercalated disc (ID), a composite adhesion site between adjacent cardiomyocytes. 3 The ID provides mechanical, electrophysiological, and metabolic linkage between neighboring cells. Cardiac desmosomes are specialized multiprotein assemblies consisting of the calcium-dependent cell-cell adhesion transmembrane proteins desmoglein 2 (Dsg2) and desmocollin 2 (Dsc2) and attached linker molecules, that is, the armadillo repeat-containing plakophilin 2 (Pkp2) and plakoglobin (Pg), and the plakin domain-containing desmoplakin (Dsp), which in turn connects to cytoskeletal desmin intermediate filaments. 4, 5 Although all desmosomal proteins have been implicated in AC, the most commonly mutated genes are those encoding Pkp2 and Dsg2. 1 The observed autosomal dominant inheritance of desmoglein 2 gene (DSG2)-related AC cases 2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] suggests that reduction of the Dsg2 wild-type (WT) protein leads to a loss of cardiac function or that Dsg2 mutant (MT) protein exerts a dominant negative effect on the remaining Dsg2 WT protein. Two major types of nonexclusive pathomechanisms have been described to depend on Dsg2. As a cell-cell adhesion molecule, it provides adhesive force and thereby supports force transmission between contractile cardiomyocytes. Alternatively, Dsg2 regulates intracellular signaling. This function is expected to be linked to the cytoplasmic domain of Dsg2 and may involve associated signaling molecules, such as Pg and Pkp2/PKCα acting through downstream effectors implicating the Wnt or Hippo pathways. 16, 17 To examine mechanisms of DSG2-related cardiomyopathy, several murine models have been established. Complete constitutive deletion of Dsg2 was shown to be embryonic lethal 18 as is the case for all other integral components of desmosomes. 5 Heterozygous DSG2 knockouts (KO) are viable and do not develop overt AC under standard animal housing conditions. 18 Subsequently, mice were generated overexpressing murine mutant Dsg2 N271S corresponding to the pathogenic human Dsg2 N266S mutation. 11 The mutation is localized in the second extracellular calcium-binding pocket, presumably contributing to Dsg2's adhesive function. These mice developed, in contrast to mice overexpressing the same amount of Dsg2 WT, symptoms of AC, including biventricular dilation, calcifying necrosis with replacement fibrosis, conduction defects, and arrhythmia, occasionally resulting in premature death. 11 Later on, a knock-in mouse model was described producing mutant Dsg2 with a deletion in the extracellular domains EC1-EC2. Live-born homozygous DSG2 MT carriers developed an AC-like phenotype during adolescence. 19, 20 The deleted part of Dsg2 includes the most aminoterminal calcium-binding site and is believed to be important for adhesion through homo-and heterophilic desmosomal cadherin interaction. 21 Thus, peptides taken from this domain prevent Dsg2-dependent adhesion, 22 and autoantibodies targeting the corresponding region in Dsg3 induce cell dissociation in pemphigus vulgaris. 23 Taken together, neither overexpression nor ≈50% reduction of WT Dsg2 induces overt cardiomyopathy. 11, 18 But overexpression of mutant Dsg2 N271S in the presence of normal WT Dsg2 levels leads to dose-dependent cardiomyopathy. 11, 24 In contrast, heterozygous mice with only one DSG2 WT and one DSG2
MT allele seem to be healthy, although a slight upregulation in transcription of the stress-response genes ANF and BNF were detected at early disease stages. 20 Furthermore, complete replacement of 2 DSG2
WT by 2 DSG2 MT alleles leads to an ≈75% reduction in Dsg2 protein expression and a pronounced AC-like phenotype. 19, 20 These observations may be explained either by loss of Dsg2-dependent adhesion or by altered cytoplasmic binding of the mutant Dsg2 to signaling molecules. To find out which mechanism is responsible for AC induction, we prepared cardiomyocyte-specific DSG2 KO mice and compared the phenotype to that observed in DSG2 MT mice.
Materials and Methods

DNA Cloning and Generation of Knockout Mice
Standard methods were used for targeting construct preparation, transfection, selection, and characterization of embryonic stem cell clones, blastocyst injection, and mouse breeding (details in Data Supplement).
The animal experiments were approved by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) Nordrhein-Westfalen under the reference number 8.87-50.10.37.09.114.
RNA Isolation, Reverse Transcription, and qRT-PCR
Total RNA was isolated from fresh tissue for preparation of cDNA and PCR amplification as specified in the Data Supplement.
Immunoblotting
Total protein extracts of fresh heart tissue were analyzed by immunoblotting as described in the Data Supplement.
Histological Stains and Immunohistology
Heart tissue was fixed in 4% formaldehyde/PBS for 12 h and subsequently embedded in paraffin. Sections were prepared and either Azan-or von Kossa-stained.
For immunofluorescence, sections were heated in citrate buffer (pH 6.0) in a pressure cooker for 3 minutes. Primary antibodies diluted in PBS/1.5% BSA were applied overnight at 4°C: polyclonal rabbit anti-Dsg2 (1:500; Dsg2 IC), 20 guinea pig-anti desmoplakin (1:1000; DP-1, Progen), mouse anti-Pkp2 (1:12; 651101, Progen), goat anti-Pg (1:75; sc-30997, Santa Cruz), and rabbit anti-Cx43 
Electron Microscopy
Before removal, the ventricular myocard was relaxed by retrograde perfusion with 4 to 5 mL relaxation buffer (30 mmol/L KCl, 300 mmol/L glucose). Heart samples were cut into cubes of ≈1 mm 3 in fixative (3.7% formaldehyde, 1% glutaraldehyde, 11.6 g NaH 2 PO 4 H 2 O, and 2.7 g NaOH per liter of ddH 2 O) and incubated for 2 h at room temperature. Incubations in 1% OsO 4 for 1 h and in 0.5% uranylactetate/0.05 mol/L sodium maleate buffer (pH 5.2) for 2 h followed. Samples were dehydrated and embedded in araldite (48 h, 60°C) using acetone as intermedium. Ultrathin sections with a thickness of 65 to 75 nm were prepared, and contrast was enhanced by treatment with 3% uranylacetate for 4 minutes followed by 3 minutes incubation in 80 mmol/L lead citrate solution. Micrographs were recorded on an EM 10 (Zeiss) upgraded with a digital camera (Olympus) using iTEM software (Olympus).
Electrocardiography
Conscious mice were placed on an ECGenie unit (Mouse Specifics Inc.) and signals were recorded for 10 minutes. The best traces, each containing at least 10 cardiac cycles, were selected and analyzed using the ECGenie software.
Statistical Methods
All results are presented as mean±SD. The mean of data gathered from 1 animal was counted as 1 n. 
Results
Conditional Depletion of Desmoglein 2 in Cardiomyocytes
To prepare mice with a cardiomyocyte-specific DSG2 knockout, we made use of a Myh6-driven Cre 25 to delete exons 4 and 5 of a floxed DSG2 allele ( Figure 1A) . First, using a targeting construct, 6 recombinant AB2.2 embryonic stem cell clones were isolated. Correct recombination was detected in 2 clones by Southern blotting using 5′-external, internal and 3′-external probes ( Figure 1A and 1B). They were injected into C57BL/6J morulae and blastocysts for transgenic line production. Transgenic animals were healthy, and the neomycin resistance gene was successfully removed by breeding with Flp o -deleter mice. 26 For cardiomyocyte-specific DSG2 inactivation, mice with the floxed DSG2 alleles were mated with Myh6-Cre transgenic mice, 25 which have been shown to initiate cardiac Cre-expression at embryonic day 7 (E7), resulting in efficient recombination of a reporter gene at E9 throughout the myocardium. 27 PCR analyses of 4 animals confirmed correct recombination ( Figure 1C ). It was, however, difficult to deduce recombination efficiency because the cardiac tissue samples contain noncardiomyocytes, such as fibroblasts, endothelial cells, smooth muscle cells, and immune cells all of which are not targeted by the Cre recombinase and do not express Dsg2. RT-PCR was therefore performed to assess the efficiency of DSG2
WT mRNA depletion. DSG2 WT mRNA was reduced to <2% in DSG2 cKO samples ( Figure 1D ). Instead, a shortened mRNA fragment was amplified. . C, Midori Green-stained, electrophoretically separated DNA fragments that were obtained by polymerase chain reaction (PCR) amplification of genomic regions surrounding the 5′ loxP site. Note that a single 167 bp fragment is amplified from DSG2 WT mice and that an additional fragment is detectable in the heart but not liver of mice that also contain the Myh6-Cre transgene. The size (236 bp) of this fragment corresponds to that expected for the recombined DSG2 cKO allele. D, Left panel, PCR products amplified from cDNA derived from heart tissue of a DSG2 Figure 1D ). On sequencing, it turned out to be a splice variant, in which 98 bp of DSG2 intron 3 (5′-ATT GGT TTA GTG GGG AAG CTT CAG GCT CGT GTG GAG GTC AGA GAA CAG CAG TGA GAG TGT CTC TCC CTC TGC CAT GTG TGT TCC AGG ACT GCA CTC AG-3′) remain between exons 3 and 6. This leads to an extension of exon 3 coding for the additional 16 amino acids GLVGKLQARVEVREQQ before a stop codon prevents further translation. Taken together, both mRNA transcripts result in nonfunctional, presumably secreted peptides of 26 and 42 amino acids, respectively.
Next, Dsg2 protein expression was examined in DSG2 cKO heart tissue. A ≈60% reduction was noted in heterozygous DSG2 WT/cKO and <3% Dsg2 were detectable in homozygous DSG2 cKO/cKO (n=4) using 2 different antibodies directed against cytoplasmic epitopes of Dsg2 (Figure 2A ). These results were confirmed by immunohistology ( Figure 2C and 2D). Of note, expression and ID localization of other desmosomal proteins, such as Dsp, Pg, and Pkp2, were not visibly affected (Figures 2B and 2E-2H; n=4). Nuclear or nonjunctional plasma membrane staining was not seen for any of these antigens. Taken together, we conclude that Myh6-Cre-induced DSG2 cKO results in efficient inhibition of Dsg2 protein expression in the hearts of transgenic mice without significantly affecting the expression level and localization of other major desmosomal proteins.
Gross Morphological Manifestation of Cardiomyopathy
Breeding heterozygous Myh6-Cre carriers with Myh6-Crenegative mice in a homozygous DSG2 flox/flox background resulted in 40% DSG2 cKO/cKO progeny instead of the expected 50% at 4 weeks after birth (n=182). This situation is less dramatic than that encountered in DSG2
MT mice expressing Dsg2 mutants lacking parts of their adhesive EC1-EC2 domains. In that instance, only 15% of the expected homozygous mutants were found at 4 weeks (n=104). Remarkably, most newborn mice appeared to be healthy in both situations. Myocardial alterations, however, became visible in all homozygous DSG2 cKO and DSG2 MT animals by the age of 4 to 6 weeks, that is, toward the end of postnatal heart growth ( Figure ID in the Data Supplement). Most conspicuous were white, nontransparent, and differently sized areas on the cardiac surface occurring in the majority of DSG2
MT and DSG2 cKO mice (Figure 3K and 3L; Figure IB and IC in the Data Supplement). Such lesions, which were never seen in DSG2
WT animals, localized in 60% on the anterolateral surface of the left ventricle near the apex of DSG2
MT hearts (n=79; see also Krusche et al 20 ) . In addition, regions were noted, in which the convex and light red-colored even surface, which 
is typically encountered in the DSG2
WT heart, was substituted by an uneven patchy dark red-colored surface (arrowheads in Figure 3I and 3J). Such alterations are characteristic features of wall thinning and aneurysms. Accordingly, enlargement of the right ventricle and both atria were observed ( Figure I in the Data Supplement). Taken together, visual inspection of the dissected hearts sufficed to detect pathological anomalies in almost 100% of DSG2
MT and DSG2 cKO animals by 4 weeks ( Figure ID in the Data Supplement).
Histological Detection of Calcifying Replacement Fibrosis and Interstitial Fibrosis
To further compare cardiac pathology between DSG2
MT and DSG2 cKO animals, detailed histological analyses were performed. Transmural fibrotic foci corresponding to the macroscopically visible surface lesions were detected by Azan staining (arrows in Figure 3C , 3C′, 3F, and 3F′). Many of them contained calcifications as determined by von Kossa staining in both genetic situations (arrows in corresponding sections shown in Figure 4C , 4C′, 4F, and 4F′). Careful examination revealed von Kossa-positive foci in up to a 100% of animals by 6 weeks. Ultrastructurally, remnants of cardiomyocytes were detected that were surrounded by calcified material (Figure 4G and 4H) , providing evidence for cardiomyocyte necrosis, which has been identified as a key event in the pathogenesis of murine AC. 11 Calcification, however, was not detectable in all lesions (arrowheads in Figure 3B , 3B′, 3E, and 3E′ and arrowheads in corresponding areas of adjacent sections shown in Figure 4B , 4B′, 4E, and 4E′). These von Kossa-negative lesions likely contribute to the continuously increasing interstitial fibrosis observed in murine AC hearts. 19 Taken together, the different types of fibrotic lesions are identical in DSG2 cKO and DSG2
MT hearts. Furthermore, comparable lesions have been identified in human AC patients with DSG2 mutations.
8,10
Disease Stages
Gross morphological appearance and histology of most hearts was normal at 2 weeks (Figures I-III which was accompanied by a reduction in CD45 cells (Figure 5D and 5F) in lesioned areas. In contrast, von Kossapositive foci persisted ( Figure III in the Data Supplement). These observations show that the timing and stages of disease progression of the newly established DSG2 cKO mice is indistinguishable from that observed in DSG2
MT animals.
Loss of Desmosome-Like Structures and Intercalated Disc Dissociation
To further work out the resemblance between DSG2 cKO and DSG2 MT hearts at the ultrastructural level, electron microscopy was performed. For best evaluation, the myocardium was relaxed before fixation. Morphology and organization of sarcomeres were not visibly altered in longitudinal sections of intact cardiomyocytes. Cell-cell contact regions contained normal-appearing fasciae adhaerentes and adjacent gap junctions. Desmosome-like structures were frequently observed in IDs of WT control mice (arrows in Figure 6A and 6A′), but were not seen in IDs of DSG2 cKO and DSG2 MT mice ( Figure 6B-6C′) .
Although intercellular gap width was not altered in most instances, dissociation of IDs was occasionally noted in the mutant hearts ( Figure 6D and 6E) , resulting in remnant junctions with adhering actin filaments. Adjacent cytoplasmic regions appeared to be disordered with multiple membranous structures and disarranged mitochondria. The disconnected intercellular gaps were usually filled with membranes and included large cytoplasmic organelles, such as mitochondria in some instances. In regions directly adjacent to fibrotic lesions, sarcomeres ended in membrane regions that were decorated by scarce plaque material and bordered directly to the collagen fiber-rich extracellular matrix ( Figure 6F and 6G).
Altered Conduction and Connexin 43 Distribution
To examine electrophysiological alterations, electrocardiography was performed using the ECGenie system ( Figure 7E and 7F). Despite normal heart rates (RR-intervals), highly significant prolonged PR and QRS intervals were detected in both the DSG2 MT (n=6) versus DSG2 WT (n=8) and DSG2 cKO (n=8) versus DSG2 flox(E4-5) control mice (n=10), indicating conduction defects of atria and ventricles. We therefore investigated the expression of the major myocardial gap junction protein connexin 43. Overall protein levels were similar in matched mutant and WT hearts ( Figure 7D ). Immunolocalization (n=5), however, revealed that connexin 43 staining was not restricted to IDs in DSG2 cKO and DSG2
MT
, but was also detectable in multiple puncta in the cytoplasm of perilesional cardiomyocytes ( Figure 7A-7C ).
Discussion
We report on the establishment and characterization of a mouse model, in which, for the first time, a desmosomal cadherin was tissue-specifically ablated in a specialized cell type, namely the cardiomyocyte. The birth of viable animals with inconspicuous gross heart morphology provides evidence that Dsg2 is not essential for growth and function of the heart during late embryogenesis and early postnatal life. This is remarkable because Dsg2 is by far the major Dsg isoform expressed in cardiomyocytes. 5 All analyses performed in this study reveal a striking phenotypic resemblance between DSG2 cKO and DSG2 MT mice. This includes aspects of disease onset and progression, histological features, ultrastructural disturbances, and functional deficiencies. Furthermore, our observations are similar to those reported for mice overexpressing Dsg2 N271S. 11 We therefore suggest that the same pathways induce cardiomyopathy in all 3 models.
The observed widening and frequent dissociation of intercalated discs in the 3 DSG2-mutant mouse strains (Kant et al 19 and Rizzo et al 24 and this study) presents strong in vivo evidence for compromised adhesion. Similar changes were noted in hearts of patients with Dsg2-related AC. 10, 12, 29 In vitro experimentation further supports an adhesive function of Dsg2. Expression of different human AC-related Dsg2 mutants and inhibition of Dsg2 adhesion were reported to reduce adhesion upon expression in HL-1 cardiomyocytes 22 (for contrasting results on another mutant see Gaertner et al 30 ). The situation in other AC types is less clear. Although some reports support an adhesion deficiency as evidenced by intercalated disc widening and dissociation in murine AC models, 31 in patient-derived iPSCs, 32 and in patients, 29 a recent publication portrays a more complex situation. 33 Depletion of either plakoglobin or plakophilin resulted in weakened cellcell adhesion as was observed by others before, 34, 35 whereas mutant polypeptides did not (for contrasting results, see, however, Sato et al 34 ). Instead, they reported on an abnormal shear stress response. 33 Given the apparent differences in the various AC disease forms and model systems, we may have to consider the disconcerting possibility that in the different scenarios the initial molecular pathomechanisms differ and merge only later in common pathways to induce the full AC phenotype.
We find it remarkable that desmosomal proteins are still efficiently recruited to and remain associated with the ID in the absence of Dsg2. In contrast, Pg depletion results in considerable loss of Dsg2, Pkp2, and Dsp at the ID. 36, 37 Similarly, Pkp2 is needed for junctional localization of Dsp and Dsg2 in embryonic heart. 38 The lack of desmosome-like structures in DSG2
cKO hearts, however, shows that Dsc2 is not able to fully compensate for the loss of Dsg2. Clearly, both cadherins are not interchangeable as is evident from the lack of overt cardiomyopathy in desmocollin 2 knockout mice. 39 The clinical manifestation of an AC-like phenotype during the postnatal growth period of young DSG2 cKO mice assigns an important function to Dsg2 in supporting the increasing workload of the growing heart. Yet, 50% reduction of Dsg2 in DSG2
WT/KO and DSG2
WT/ cKO mice still supports overall normal heart function (this study and Eshkind et al 18 ), although physical challenges may induce AC symptoms as has been observed in heterozygous Pg KO mice. 40 In the situation of homozygous DSG2 MT mice, both the adhesion defect of the mutant polypeptide and the reduction of the mutant Dsg2 to ≈25% likely contribute to AC-like pathogenesis. 20 The new DSG2 cKO mouse model provides proof that downregulation of Dsg2 below a critical level induces a cardiomyopathy that is similar to that observed in DSG2 MT mice. Of note, not only Dsg2 reduction but also overexpression of Dsg2 N271S leads to cardiomyopathy. Because overexpression of WT Dsg2 alone does not induce cardiomyopathy, one has to conclude that Dsg2 N271S interferes with WT Dsg2 function by a dominant negative mechanism. 11 Interestingly, high overexpression results in a more severe phenotype than low overexpression. 11 Given that Dsg2 N271S induces an AC-like phenotype in the presence of WT Dsg2, it is not clear why Dsg2 lacking the EC1-EC2 domains does not. Reasons for this discrepancy may be that deletion of the EC1-EC2 segment is less severe than the single amino acid change in the Dsg2 N271S or that the level of mutant protein expression is relevant for disease development. In all instances, interference seems to occur at the ID because mutant Dsg2 is efficiently localized to the ID in the different murine models and human Dsg2-related AC. 8, 11, 20, 30, 41 Multiple studies have assigned a crucial role of plakoglobin signaling to the initiation of AC in mouse and man. 17, [42] [43] [44] Comparing disease manifestation with the available binding sites of desmosomal cadherins for Pg or other desmosomal cadherin-dependent signaling molecules in the various murine models, however, shows that there is no clear correlation (Figure 8 ). We therefore conclude that altered Dsg2 cytoplasmic tail-dependent signaling, which relies on Pg displacement from the desmosome, is unlikely the major disease mechanism. This is also supported by AC development either in the absence of Pg 36, 37 or with unperturbed Pg expression in the ID. 45 Instead, compromised desmosomal cadherin-mediated adhesion may be at the core of disease initiation. This concept is strongly supported by the loss-of-function phenotype observed in the present study. It is indirectly supported by the observation that AC-associated Dsg2 mutations in the intracellular catenin-binding domain do not compromise Pg-or Pkp2-binding. 8 It is of interest to note that Dsg2 reduction has also been observed in the hearts of PKP2 KO/KO embryos, 38 in heart-specific homozygous Pg knock-outs (JUP cKO/cKO ), 36, 37 and in the presence of normal Pg ID expression in a heartspecific Dsp knock-out. 45 Similar to the observations reported here, a selective loss of desmosome-like structures but not of adherens junctions and gap junctions was detected in the JUP cKO/cKO . 36, 37 In addition, Dsg2 downregulation has also been observed in human AC patients independent of the underlying mutations, even in the presence of normal Pg localization to IDs. 46 A provocative conclusion is that downregulation of Pg and Pkp2 may also lead to weakening of desmosomal cadherin-mediated adhesion and desmin intermediate filament anchorage. DSP mutations 31, 45 and certain desmin mutations 47, 48 may contribute in a similar fashion to impair the stability and resilience of the desmosome-based transcellular scaffold. Thus, altered adhesion may be the primary dysfunction of desmosome-related cardiomyopathy that can be brought about in different ways as reflected by the different desmosomal gene mutations reported to date.
Limitations
Murine models of human AC present significant limitations given the differences in genetics, life span, immune response, epicardial fat, and secondary reactions, such as fibrotic scar formation with calcinosis typical in mice 49 versus fibrotic replacement in human with variable amounts of adipose tissue. 50 In addition, several aspects of our murine AC models remain to be explored. These include the analysis of embryonic lethality, detailed statistics of survival, examination of the effect of physical activity on modulating disease progression WT ; cKO, DSG2 cKO ). E, Typical examples of averaged ECGenie recordings of ≈20-week-old mice that were used for further analysis. F, Histogram depicting RR, PR, and QRS intervals determined in wild-type (WT at left; n=6) versus DSG2 MT (MT; n=8) and DSG2 flox(E4-5) (WT at right; n=10) versus DSG2 cKO (cKO; n=8) animals. Note the significant increase in PR and QRS intervals in both instances (**P<0.01; ***P<0.001). in homozygous mutants, and even more, the induction of disease symptoms in heterozygotes.
